Evidence map›Paper›PMID 29375499›Full record

ArticleFrontiers in microbiology2017

Identification of the Autochaperone Domain in the Type Va Secretion System (T5aSS): Prevalent Feature of Autotransporters with a β-Helical Passenger.

Maricarmen Rojas-Lopez, Mohamed A Zorgani, Lawrence A Kelley, Xavier Bailly, Andrey V Kajava, Ian R Henderson, Fabio Polticelli, Mariagrazia Pizza, Roberto Rosini, Mickaël Desvaux

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Identification of theProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Identification of the adhesive domain of AtaA fromFrontiers in bioengineering and biotechnology · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Maricarmen Rojas-LopezUniversité Clermont Auvergne, INRA, UMR454 MEDiS, Clermont-Ferrand, France.
Mohamed A ZorganiUniversité Clermont Auvergne, INRA, UMR454 MEDiS, Clermont-Ferrand, France.
Lawrence A KelleyStructural Bioinformatics Group, Imperial College London, London, United Kingdom.
Xavier BaillyInstitut National de la Recherche Agronomique, UR346 Epidémiologie Animale, Saint Genès Champanelle, France.
Andrey V KajavaCRBM UMR5237 CNRS, Institut de Biologie Computationnelle, Université Montpellier, Montpellier, France.
Ian R HendersonInstitute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Fabio PolticelliDepartment of Sciences, National Institute of Nuclear Physics, Roma Tre University, Rome, Italy.
Mariagrazia PizzaGSK, Siena, Italy.
Roberto RosiniGSK, Siena, Italy.
Mickaël DesvauxUniversité Clermont Auvergne, INRA, UMR454 MEDiS, Clermont-Ferrand, France.
Université Clermont Auvergne · FRCentre National de la Recherche Scientifique · FRDépartement Génétique Animale · FRImperial College London · GBRoma Tre University · ITUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autotransporters (ATs) belong to a family of modular proteins secreted by the Type V, subtype a, secretion system (T5aSS) and considered as an important source of virulence factors in lipopolysaccharidic diderm bacteria (archetypical Gram-negative bacteria). While exported by the Sec pathway, the ATs are further secreted across the outer membrane via their own C-terminal translocator forming a β-barrel, through which the rest of the protein, namely the passenger, can pass. In several ATs, an autochaperone domain (AC) present at the C-terminal region of the passenger and upstream of the translocator was demonstrated as strictly required for proper secretion and folding. However, considering it was functionally characterised and identified only in a handful of ATs, wariness recently fells on the commonality and conservation of this structural element in the T5aSS. To circumvent the issue of sequence divergence and taking advantage of the resolved three-dimensional structure of some ACs, identification of this domain was performed following structural alignment among all AT passengers experimentally resolved by crystallography before searching in a dataset of 1523 ATs. While demonstrating that the AC is indeed a conserved structure found in numerous ATs, phylogenetic analysis further revealed a distribution into deeply rooted branches, from which emerge 20 main clusters. Sequence analysis revealed that an AC could be identified in the large majority of SAATs (self-associating ATs) but not in any LEATs (lipase/esterase ATs) nor in some PATs (protease autotransporters) and PHATs (phosphatase/hydrolase ATs). Structural analysis indicated that an AC was present in passengers exhibiting single-stranded right-handed parallel β-helix, whatever the type of β-solenoid, but not with α-helical globular fold. From this investigation, the AC of type 1 appears as a prevalent and conserved structural element exclusively associated to β-helical AT passenger and should promote further studies about the protein secretion and folding via the T5aSS, especially toward α-helical AT passengers.

Indexed as

Autochaperone domainAutotransportersdiderm-LPS Gram-negative bacteriaOuter membrane proteinsprotein secretion systemProtein translocationType V secretion system

Identifiers

PMID29375499
PMCPMC5767081
OpenAlexW2781794800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.